See the DrugPatentWatch profile for Colistimethate
What is colistimethate sodium injection used to treat?
Colistimethate sodium injection is used to treat severe infections caused by certain Gram-negative bacteria, especially when bacteria are resistant to other antibiotics. It’s a polymyxin-type antibiotic given by injection (IV or sometimes IM/into a body site depending on the product and regimen).
Which infections are commonly treated with it?
In clinical practice, colistimethate sodium injection is most often used for serious hospital-acquired or ventilator-associated infections, including infections caused by difficult-to-treat multidrug-resistant organisms. It may be used when the likely bacteria are susceptible and treatment options are limited.
Why is it used only in certain cases?
This medicine is typically reserved for hard-to-treat resistant infections because it has significant risk of kidney toxicity and can cause other side effects. Clinicians generally use it when benefits outweigh the risks and when culture results or strong clinical suspicion support its use.
How is it usually given?
Colistimethate sodium injection is administered by healthcare professionals, most commonly intravenously for systemic treatment. The exact route, dose, and timing depend on the site and severity of infection and on kidney function.
What happens if kidney function is affected?
Because colistimethate sodium can affect the kidneys, dosing often needs adjustment in patients with impaired renal function, and clinicians monitor kidney labs during therapy to reduce toxicity risk.
What side effects do people ask about most?
Common concerns include kidney-related effects (nephrotoxicity) and, with polymyxins, possible effects on the nervous system or neuromuscular function. Side effects vary by dose and patient factors, so monitoring is part of standard use.
Is it the same as colistin?
Colistimethate sodium is converted in the body to the active form used for antibacterial activity. That conversion and dosing can be confusing, so clinicians usually follow product-specific dosing and labeling instructions for colistimethate sodium.
Important safety note
This drug should be used only under medical supervision. The correct dose depends heavily on kidney function and the specific bacteria being treated, so it’s not interchangeable or “self-dosed.”
Sources
I don’t have the specific prescribing information or guidelines you want me to rely on. If you share the product label (brand name and strength) or a link/document, I can extract the exact “uses/indications” wording and any key details (routes, dosing cautions, and monitoring) verbatim from that source.